Inspiration Research Contributes to Groundbreaking Study

2019-06-18T23:57:42+00:00

Inspiration Research Contributes to Groundbreaking Study KAMADA Pharmaceutical ("Kamada") conducted a Phase II/III clinical trial on the efficacy of proprietary inhaled Alpha-­1 Antitrypsin (AAT) therapy for the treatment of Alpha-­1 Antitrypsin Deficiency (AATD or inherited emphysema) which involved a multi-centre, randomized, double-blind, placebo-controlled study designed to evaluate Kamada's formulation of human AAT to [...]